|European Pharma Summit|
Kinase Inhibitors in Drug Discovery
GPCR Targeted Screening
Drug Design & Medicinal Chemistry
We invite you to attend the 5th GPCR Targeted Screening Conference, which will take place on November 16-17, 2017 in Berlin, Germany. G protein-coupled receptors are the largest family of protein receptors and account for one of the largest classes for drug targets currently in the market. Continued breakthrough and insights into the structural biology of GPCRs have opened up greater potential of this target class to impact drug discovery and renewed interest in this field.
The landscape for drug discovery has changed drastically over the past few years: private and public partnerships are changing how research is being done, researchers are using 3D model systems in hopes of improving clinical outcomes, and emerging target classes are changing traditional conceptions of the drug discovery process.
Leaders in the field will share about advances in topics such as GPCRs in diseases, approaches to GPCR signaling, and biased signaling. Join us as we discuss basic biology to translational research in the field of GPCRs and gather for dedicated networking sessions with colleagues from academia and industry.
We hope to see you there!
The 2017 Advisory Committee
Amber Kempf at 626-256-6405 x110 or amber.kempf [at] gtcbio.com
For more information on Media Relations, please contact:
Jennifer Chu at 626-256-6405 x105 or jennifer.chu [at] gtcbio.com